A new paradigm in medicine. Unlocking intractable drug targets with exosites.
ExoSight™: A comprehensive platform to expand the universe of druggable enzymes.
Modulating enzyme activity in oncology and inflammation with precision and potency.
Join us in charting new territory on our mission to develop breakthrough medicines.
recent news
Exo Therapeutics Presents Data on Novel Exosite Inhibitors of TBK1 (EXO-TBKi) Shown to Disrupt Pathological STING-mediated TBK1 Activation at American College of Rheumatology’s Convergence (ACR)
Exo Therapeutics Announces Late Breaking Poster at American College of Rheumatology’s Convergence (ACR)
